Pharmacological properties of indapamide - Rationale for use in hypertension

被引:27
作者
Bataillard, A
Schiavi, P
Sassard, J
机构
[1] Fac Pharm Lyon, CNRS, ESA 5014, Dept Physiol & Pharmacol Clin, F-69373 Lyon 08, France
[2] Inst Rech Int Servier, F-92415 Courbevoie, France
关键词
D O I
10.2165/00003088-199937001-00002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Indapamide is a thiazide-related diuretic drug with antihypertensive properties. Its blood pressure-lowering action has been repeatedly demonstrated in acute as well as chronic conditions in various genetically and nongenetically determined forms of hypertension. In rats, the maximally effective oral dose is 3 mg/kg/24h. The natriuretic effect of indapamide peaked at 3-fold at a dose of 1 mg/kg. In accordance with its antihypertensive properties, indapamide was shown to have excellent efficacy in protecting against target organ damage (heart, kidneys, brain). In addition to its natriuretic effect, it has been shown in several experiments that indapamide lowers the response to sympathetic nerve stimulation, exhibits calcium antagonist properties, enhances the production of prostacyclin, and limits the production of free radicals and of endothelium-dependent vasoconstrictor substances. These effects, even though they are observed at high indapamide concentrations and in a possibly species-dependent manner, may contribute to the beneficial properties of indapamide. The most recent data suggest that low doses of indapamide exert synergistic effects in combination with other antihypertensive drugs such as ACE inhibitors, the effects of which are influenced by the sodium status of the organism.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 33 条
[1]   CAROTID-ARTERY MECHANICAL-PROPERTIES OF DAHL SALT-SENSITIVE RATS [J].
BENETOS, A ;
BOUAZIZ, H ;
ALBALADEJO, P ;
GUEZ, D ;
SAFAR, ME .
HYPERTENSION, 1995, 25 (02) :272-277
[2]  
BENETOS A, 1992, J HYPERTENS, V10, pS127
[3]  
BENTAHILA S, 1991, ARCH MAL COEUR, V84, P39
[4]   INDAPAMIDE INHIBITS ENDOTHELIUM-DEPENDENT CONTRACTIONS IN THE AORTA OF THE SPONTANEOUSLY HYPERTENSIVE RAT [J].
BOULANGER, CM ;
MOMBOULI, JV ;
VANHOUTTE, PM .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1993, 7 (08) :443-448
[5]   INVITRO AND EXVIVO INHIBITION OF THE MODIFICATION OF LOW-DENSITY-LIPOPROTEIN BY INDAPAMIDE [J].
BREUGNOT, C ;
ILIOU, JP ;
PRIVAT, S ;
ROBIN, F ;
VILAINE, JP ;
LENAERS, A .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 (03) :340-347
[6]   EFFECT OF INDAPAMIDE ON VOLUME-DEPENDENT HYPERTENSION, RENAL HEMODYNAMICS, SOLUTE EXCRETION AND PROXIMAL NEPHRON FRACTIONAL REABSORPTION IN THE DOG [J].
BURKE, TJ ;
NOBLES, EM ;
WOLF, PS ;
ERICKSON, AL .
CURRENT MEDICAL RESEARCH AND OPINION, 1983, 8 :25-37
[7]   DIURETIC EFFECTS ON CARDIAC-HYPERTROPHY IN THE STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RAT [J].
CONTARD, F ;
GLUKHOVA, M ;
MAROTTE, F ;
NARCISSE, G ;
SCHATZ, C ;
SWYNGHEDAUW, B ;
GUEZ, D ;
SAMUEL, JL ;
RAPPAPORT, L .
CARDIOVASCULAR RESEARCH, 1993, 27 (03) :429-434
[8]   ARTERIAL SMOOTH-MUSCLE CELL PHENOTYPE IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS [J].
CONTARD, F ;
SABRI, A ;
GLUKHOVA, M ;
SARTORE, S ;
MAROTTE, F ;
POMIES, JP ;
SCHIAVI, P ;
GUEZ, D ;
SAMUEL, JL ;
RAPPAPORT, L .
HYPERTENSION, 1993, 22 (05) :665-676
[9]   EFFECTS OF INDAPAMIDE ON CONTRACTILE RESPONSES AND CA-45(2+) MOVEMENTS IN VARIOUS ISOLATED BLOOD-VESSELS [J].
DELRIO, M ;
CHULIA, T ;
GONZALEZ, P ;
TEJERINA, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 250 (01) :133-139
[10]  
DELRIO M, 1995, J CARDIOVASC PHARM, V25, P973